Annual Revenue
$288.75 M
+$234.78 M+435.04%
December 31, 2023
Summary
- As of February 7, 2025, ASND annual revenue is $288.75 million, with the most recent change of +$234.78 million (+435.04%) on December 31, 2023.
- During the last 3 years, ASND annual revenue has risen by +$280.81 million (+3536.44%).
- ASND annual revenue is now at all-time high.
Performance
ASND Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$63.61 M
+$24.84 M+64.10%
September 30, 2024
Summary
- As of February 7, 2025, ASND quarterly revenue is $63.61 million, with the most recent change of +$24.84 million (+64.10%) on September 30, 2024.
- Over the past year, ASND quarterly revenue has increased by +$11.31 million (+21.62%).
- ASND quarterly revenue is now -57.11% below its all-time high of $148.29 million, reached on December 31, 2023.
Performance
ASND Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$354.82 M
+$11.31 M+3.29%
September 30, 2024
Summary
- As of February 7, 2025, ASND TTM revenue is $354.82 million, with the most recent change of +$11.31 million (+3.29%) on September 30, 2024.
- Over the past year, ASND TTM revenue has increased by +$191.35 million (+117.06%).
- ASND TTM revenue is now -0.45% below its all-time high of $356.43 million, reached on March 31, 2024.
Performance
ASND TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ASND Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +435.0% | +21.6% | +117.1% |
| 3 y3 years | +3536.4% | +4746.9% | +8594.8% |
| 5 y5 years | +2211.1% | +2450.3% | +2261.2% |
ASND Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3037.7% | -57.1% | +1035.7% | -0.5% | +3823.4% |
| 5 y | 5-year | at high | +3536.4% | -57.1% | +9871.0% | -0.5% | +8594.8% |
| alltime | all time | at high | >+9999.0% | -57.1% | >+9999.0% | -0.5% | >+9999.0% |
Ascendis Pharma A/S Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $63.61 M(+64.1%) | $354.82 M(+3.3%) |
| Jun 2024 | - | $38.76 M(-62.8%) | $343.51 M(-3.6%) |
| Mar 2024 | - | $104.16 M(-29.8%) | $356.43 M(+23.6%) |
| Dec 2023 | $288.75 M(+435.0%) | $148.29 M(+183.5%) | $288.35 M(+76.4%) |
| Sep 2023 | - | $52.30 M(+1.2%) | $163.47 M(+29.2%) |
| Jun 2023 | - | $51.68 M(+43.3%) | $126.57 M(+55.4%) |
| Mar 2023 | - | $36.08 M(+54.1%) | $81.45 M(+53.6%) |
| Dec 2022 | $53.97 M(+486.4%) | $23.41 M(+52.0%) | $53.04 M(+50.6%) |
| Sep 2022 | - | $15.40 M(+134.7%) | $35.23 M(+66.7%) |
| Jun 2022 | - | $6.56 M(-14.4%) | $21.14 M(+33.7%) |
| Mar 2022 | - | $7.66 M(+36.8%) | $15.81 M(+74.8%) |
| Dec 2021 | $9.20 M(+15.9%) | $5.60 M(+326.8%) | $9.04 M(+121.6%) |
| Sep 2021 | - | $1.31 M(+6.5%) | $4.08 M(-31.9%) |
| Jun 2021 | - | $1.23 M(+37.0%) | $5.99 M(-5.5%) |
| Mar 2021 | - | $898.90 K(+40.9%) | $6.34 M(-19.7%) |
| Dec 2020 | $7.94 M(-47.0%) | $637.90 K(-80.2%) | $7.90 M(-21.3%) |
| Sep 2020 | - | $3.22 M(+103.9%) | $10.04 M(+7.8%) |
| Jun 2020 | - | $1.58 M(-35.6%) | $9.31 M(-17.9%) |
| Mar 2020 | - | $2.46 M(-11.6%) | $11.33 M(-24.6%) |
| Dec 2019 | $14.97 M | $2.78 M(+11.3%) | $15.03 M(-38.0%) |
| Sep 2019 | - | $2.49 M(-30.9%) | $24.25 M(+11.3%) |
| Jun 2019 | - | $3.61 M(-41.3%) | $21.78 M(+19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $6.15 M(-48.7%) | $18.19 M(+50.6%) |
| Dec 2018 | $12.49 M(+621.1%) | $12.00 M(>+9900.0%) | $12.08 M(+2853.4%) |
| Sep 2018 | - | $23.30 K(+8.4%) | $408.90 K(-54.4%) |
| Jun 2018 | - | $21.50 K(-37.5%) | $895.80 K(-34.3%) |
| Mar 2018 | - | $34.40 K(-89.6%) | $1.36 M(-21.0%) |
| Dec 2017 | $1.73 M(-66.0%) | $329.70 K(-35.4%) | $1.72 M(-31.6%) |
| Sep 2017 | - | $510.20 K(+4.4%) | $2.52 M(-24.0%) |
| Jun 2017 | - | $488.50 K(+23.3%) | $3.31 M(-19.3%) |
| Mar 2017 | - | $396.30 K(-64.8%) | $4.11 M(-19.4%) |
| Dec 2016 | $5.10 M(-43.4%) | $1.13 M(-13.8%) | $5.10 M(-16.9%) |
| Sep 2016 | - | $1.30 M(+1.7%) | $6.14 M(-14.6%) |
| Jun 2016 | - | $1.28 M(-7.5%) | $7.19 M(-10.7%) |
| Mar 2016 | - | $1.39 M(-35.8%) | $8.05 M(-10.7%) |
| Dec 2015 | $9.01 M(-51.6%) | $2.16 M(-8.1%) | $9.01 M(-13.2%) |
| Sep 2015 | - | $2.35 M(+9.6%) | $10.38 M(-15.8%) |
| Jun 2015 | - | $2.15 M(-8.6%) | $12.33 M(-20.7%) |
| Mar 2015 | - | $2.35 M(-33.5%) | $15.55 M(-16.7%) |
| Dec 2014 | $18.60 M(-31.4%) | $3.53 M(-18.1%) | $18.68 M(-17.8%) |
| Sep 2014 | - | $4.31 M(-19.7%) | $22.71 M(+23.4%) |
| Jun 2014 | - | $5.37 M(-1.9%) | $18.41 M(+41.2%) |
| Mar 2014 | - | $5.47 M(-27.7%) | $13.04 M(+72.3%) |
| Dec 2013 | $27.10 M(+35.3%) | $7.57 M | $7.57 M |
| Dec 2012 | $20.03 M | - | - |
FAQ
- What is Ascendis Pharma A/S annual revenue?
- What is the all time high annual revenue for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual revenue year-on-year change?
- What is Ascendis Pharma A/S quarterly revenue?
- What is the all time high quarterly revenue for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly revenue year-on-year change?
- What is Ascendis Pharma A/S TTM revenue?
- What is the all time high TTM revenue for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM revenue year-on-year change?
What is Ascendis Pharma A/S annual revenue?
The current annual revenue of ASND is $288.75 M
What is the all time high annual revenue for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual revenue is $288.75 M
What is Ascendis Pharma A/S annual revenue year-on-year change?
Over the past year, ASND annual revenue has changed by +$234.78 M (+435.04%)
What is Ascendis Pharma A/S quarterly revenue?
The current quarterly revenue of ASND is $63.61 M
What is the all time high quarterly revenue for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly revenue is $148.29 M
What is Ascendis Pharma A/S quarterly revenue year-on-year change?
Over the past year, ASND quarterly revenue has changed by +$11.31 M (+21.62%)
What is Ascendis Pharma A/S TTM revenue?
The current TTM revenue of ASND is $354.82 M
What is the all time high TTM revenue for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM revenue is $356.43 M
What is Ascendis Pharma A/S TTM revenue year-on-year change?
Over the past year, ASND TTM revenue has changed by +$191.35 M (+117.06%)